During the past decade, Parkway Cardiology Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkway Cardiology Associates" #1 sponsor was "Amgen" with 2 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Montreal Heart Institute" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkway Cardiology Associates" #1 collaborator was "Duke Clinical Research Institute" with 4 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Parkway Cardiology Associates" are "ASCVD" (1 trials), "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Genetics of Drug Metabolism" (1 trials). Many other conditions were trialed in "Parkway Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Parkway Cardiology Associates" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban" (2 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parkway Cardiology Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Parkway Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Parkway Cardiology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Parkway Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".